Quantbot Technologies’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-534
Closed -$51.2K – 1708
2023
Q2
$51.2K Sell
534
-435
-45% -$43.3K ﹤0.01% 1319
2023
Q1
$97.7K Buy
+969
New +$148K 0.01% 1096
2022
Q4
– Sell
-404
Closed -$386K – 1827
2022
Q3
$386K Buy
404
+347
+609% +$345K 0.03% 663
2022
Q2
$38K Sell
57
-116
-67% -$71.9K ﹤0.01% 1352
2022
Q1
$119K Buy
173
+18
+12% +$13.9K 0.01% 997
2021
Q4
$140K Sell
155
-13
-8% -$12.4K 0.01% 805
2021
Q3
$168K Buy
+168
New +$124K 0.01% 841
2021
Q2
– Sell
-13
Closed -$9K – 1595
2021
Q1
$9K Buy
+13
New +$10.5K ﹤0.01% 1255
2020
Q4
– Sell
-10
Closed -$9K – 1430
2020
Q3
$9K Buy
+10
New +$10.6K ﹤0.01% 1127

Other funds holding GOSS

Quantbot Technologies's GOSS Position: Q3 2023 in Review

Quantbot Technologies sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 534 shares — an estimated $51.2K sold.

Quantbot Technologies first reported a position in GOSS in Q3 2020 and held it in 9 quarters. The position peaked at $386K in Q3 2022. 94 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Quantbot Technologies reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Quantbot Technologies sold 534 Gossamer Bio shares in Q3 2023, an estimated $51.2K.
  • Quantbot Technologies first reported a position in Gossamer Bio in Q3 2020 and held it in 9 quarters.
  • Quantbot Technologies's Gossamer Bio position peaked at $386K in Q3 2022.
  • 94 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Quantbot Technologies's 13F filing for Q3 2023, filed 7 Nov 2023.